1. Home
  2. XBIO vs AGMH Comparison

XBIO vs AGMH Comparison

Compare XBIO & AGMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XBIO
  • AGMH
  • Stock Information
  • Founded
  • XBIO N/A
  • AGMH 2015
  • Country
  • XBIO United States
  • AGMH Hong Kong
  • Employees
  • XBIO N/A
  • AGMH N/A
  • Industry
  • XBIO Biotechnology: Pharmaceutical Preparations
  • AGMH EDP Services
  • Sector
  • XBIO Health Care
  • AGMH Technology
  • Exchange
  • XBIO Nasdaq
  • AGMH Nasdaq
  • Market Cap
  • XBIO 5.9M
  • AGMH 6.5M
  • IPO Year
  • XBIO N/A
  • AGMH 2018
  • Fundamental
  • Price
  • XBIO $2.54
  • AGMH $3.16
  • Analyst Decision
  • XBIO Hold
  • AGMH
  • Analyst Count
  • XBIO 1
  • AGMH 0
  • Target Price
  • XBIO N/A
  • AGMH N/A
  • AVG Volume (30 Days)
  • XBIO 72.1K
  • AGMH 43.1K
  • Earning Date
  • XBIO 11-13-2025
  • AGMH 12-04-2025
  • Dividend Yield
  • XBIO N/A
  • AGMH N/A
  • EPS Growth
  • XBIO N/A
  • AGMH N/A
  • EPS
  • XBIO N/A
  • AGMH 16.43
  • Revenue
  • XBIO $2,858,935.00
  • AGMH $48,526,743.00
  • Revenue This Year
  • XBIO $1.99
  • AGMH N/A
  • Revenue Next Year
  • XBIO $20.00
  • AGMH N/A
  • P/E Ratio
  • XBIO N/A
  • AGMH $0.15
  • Revenue Growth
  • XBIO 13.30
  • AGMH 18.80
  • 52 Week Low
  • XBIO $2.20
  • AGMH $1.09
  • 52 Week High
  • XBIO $13.93
  • AGMH $97.00
  • Technical
  • Relative Strength Index (RSI)
  • XBIO 38.98
  • AGMH 31.76
  • Support Level
  • XBIO $2.51
  • AGMH $2.84
  • Resistance Level
  • XBIO $2.70
  • AGMH $3.45
  • Average True Range (ATR)
  • XBIO 0.20
  • AGMH 0.29
  • MACD
  • XBIO -0.04
  • AGMH -0.01
  • Stochastic Oscillator
  • XBIO 18.26
  • AGMH 16.47

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.

About AGMH AGM Group Holdings Inc.

AGM Group Holdings Inc is an integrated technology company. The company focuses on blockchain-oriented ASIC chip design, high-end crypto miner production, and fintech technology software services. The company generates maximum revenue from the sale of cryptocurrency mining machines and standardized computing equipment.

Share on Social Networks: